Physician profile
Roman Trimba
NPI 1225393747
$33,012.27
in general payments reported to CMS, 2019-2025
21 companies · $1,684 in 2025
The $1,684 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $146 · 2021: $575 · 2022: $833 · 2023: $1,654 · 2024: $1,960 · 2025: $1,684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,909 · Travel and Lodging: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,908.95 |
| Travel and Lodging | $389.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $23,336.03 | 2019-2023 | Pulse, Propel, Alif |
| Alphatec Spine, INC | $2,063.31 | 2019 | |
| Boston Scientific Corporation | $1,926.82 | 2019-2025 | Wavewriter Alpha Prime 16, General - Therapies, Clinical Trial Product |
| Medtronic, INC. | $1,529.54 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Globus Medical, INC. | $1,249.38 | 2024-2025 | Xlif, Modulus, Alif |
| Stryker Corporation | $586.02 | 2019-2023 | Blueprint Patient Specific Instrumentation |
| Depuy Synthes Sales INC. | $434.39 | 2019-2021 | |
| Abbott Laboratories | $433.44 | 2023-2025 | Proclaim, Eterna |
| Medtronic USA, INC. | $362.34 | 2019 | |
| Nevro Corp. | $289.35 | 2023-2024 | Senza |
| Kerecis Limited | $176.15 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Zimmer Biomet Holdings, INC. | $175.90 | 2019 | |
| Relievant Medsystems, INC. | $158.45 | 2023 | Intracept |
| Baylis Medical Company INC | $108.52 | 2019 | |
| Pfizer INC. | $74.44 | 2024-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $22.97 | 2025 | Evoke |
| Si-Bone, INC. | $19.86 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $17.76 | 2025 | |
| Ferring Pharmaceuticals INC. | $16.66 | 2022 | |
| Baxter Healthcare | $16.52 | 2025 | Perclot |
| Highridge Medical LLC | $14.42 | 2024 | Mobi-C Plug & Fit US |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roman Trimba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.